Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nasopharyngeal carcinoma.

Muhyi Al-Sarraf1, Maryada S Reddy

  • 1Rose Cancer Center, William Beaumont Hospital, 3577 West 13 Mile Road, Suite 404, Royal Oak, MI 48073, USA. mealsarraf@aol.com

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary

Advanced nasopharyngeal carcinoma treatment has evolved significantly. Combining chemotherapy with radiotherapy, particularly sequential or concurrent approaches, dramatically improves 5-year survival rates for stage IV disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

International journal of radiation oncology, biology, physics·2005
Same author

Head and neck cancers.

Cancer chemotherapy and biological response modifiers·2005
Same author

Head and neck cancers.

Cancer chemotherapy and biological response modifiers·2004
Same author

Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2003
Same author

Head and neck cancer.

Cancer chemotherapy and biological response modifiers·2003
Same author

Treatment of locally advanced head and neck cancer: historical and critical review.

Cancer control : journal of the Moffitt Cancer Center·2002

Area of Science:

  • Oncology
  • Radiotherapy
  • Medical Chemotherapy

Background:

  • Nasopharyngeal carcinoma (NPC) often presents as locally advanced disease (Stage III/IV).
  • Historically, radiotherapy alone yielded poor 5-year survival rates (<30% for Stage IVM0).
  • High rates of local, regional, and systemic recurrence contributed to low survival.

Purpose of the Study:

  • To review the evolution of treatment strategies for advanced nasopharyngeal carcinoma.
  • To assess the impact of different chemotherapy and radiotherapy combinations on survival rates.
  • To evaluate treatment outcomes for recurrent or metastatic NPC.

Main Methods:

  • Review of treatment modalities for nasopharyngeal carcinoma.
  • Analysis of survival data based on sequential and concurrent chemoradiotherapy regimens.
  • Evaluation of chemotherapy effectiveness in recurrent and metastatic settings.

Main Results:

  • Sequential chemotherapy followed by radiotherapy improved 5-year survival to 55%.
  • Concurrent chemoradiotherapy (single-agent cisplatin) also achieved 55% 5-year survival.
  • Combined modality treatment (concurrent chemoradiotherapy + adjuvant chemotherapy) reached ~75% 5-year survival.
  • Reversing sequence to chemotherapy followed by concurrent chemoradiotherapy showed potential for up to 90% 5-year survival.

Conclusions:

  • Chemoradiotherapy significantly enhances survival for advanced nasopharyngeal carcinoma.
  • Optimizing treatment sequence (chemotherapy before concurrent chemoradiotherapy) may further improve outcomes.
  • Chemotherapy remains crucial for managing recurrent or metastatic disease, with salvage rates around 15-20%.

Related Experiment Videos